# Molecular Diagnostics | Invivoscribe | Precision Diagnostics in San Diego, CA > Markdown mirror of DialtoneApp's public top-site detail page for `invivoscribe.com`. URL: https://dialtoneapp.com/top-sites/invivoscribe.com/index.md Canonical HTML: https://dialtoneapp.com/top-sites/invivoscribe.com ## Summary - Domain: `invivoscribe.com` - Website: https://invivoscribe.com - Description: ai readable | score 20 | purchase read only - Label: ai_readable - Payment surface: Not available - Purchase boundary: read_only - Control boundary: unknown - Rank: 662187 ## robots ~~~text User-Agent: * Allow: /wp-content/uploads/ Disallow: /wp-content/plugins/ Disallow: /wp-admin/ Disallow: /readme.html Disallow: /refer/ # ------------------------------------------- # Allowed AI Agents (Search & Assistants) # ------------------------------------------- User-agent: OAI-SearchBot User-agent: ChatGPT-User User-agent: PerplexityBot User-agent: FirecrawlAgent User-agent: AndiBot User-agent: ExaBot User-agent: PhindBot User-agent: YouBot User-agent: BingBot User-agent: Claude-Web User-agent: ClaudeBot User-agent: GPTBot User-agent: Google-Extended Crawl-delay: 5 Allow: / Sitemap: https://invivoscribe.com/post-sitemap.xml Sitemap: https://invivoscribe.com/page-sitemap.xml Sitemap: https://invivoscribe.com/product-sitemap.xml ~~~ ## llms ~~~text > Business Description: Invivoscribe is an industry pioneer in precision diagnostics. We have 30 years of experience developing and manufacturing diagnostic products and reagents for leukemias and lymphomas. All of our diagnostic tests generate meaningful results allowing healthcare providers to confirm or modify treatment for each patient. - [Invivoscribe Announces Long-Term Collaboration to Develop Immuno-Oncology Tests With Thermo Fisher Scientific - Invivoscribe](https://invivoscribe.com/invivoscribe-announces-long-term-collaboration-to-develop-immuno-oncology-tests-with-thermo-fisher-scientific/): Invivoscribe Announces Long-Term Collaboration to Develop Immuno-Oncology Tests With Thermo Fisher Scientifi - [Explore the Benefits, Considerations, and Utility of NGS B- and T-cell Clonality - Invivoscribe](https://invivoscribe.com/explore-the-benefits-considerations-and-utility-of-ngs-b-and-t-cell-clonality/): Expert pathologistsÿshare insight on the transition from capillary electrophoresis to NGS, the opportunities and challenges with NGS technology, and considerations for enhancing results. - [Japan?s MHLW Approves Invivoscribe?s LeukoStrat CDx FLT3 Mutation Assay as the CDx for Daiichi Sankyo?s Quizartinib for Treatment of Relapsed/Refractory FLT3-ITD AML. Expands Use to Include Specimens Collected in EDTA - Invivoscribe](https://invivoscribe.com/japans-mhlw-approves-invivoscribes-leukostrat-cdx-flt3-mutation-assay-as-the-cdx-for-daiichi-sankyos-quizartinib-for-treatment-of-relapsed-refractory-flt3-itd-aml-expands/): Japan?s MHLW Approves Invivoscribe?s LeukoStrat CDx FLT3 Mutation Assay as the CDx for Daiichi Sankyo?s Quizartinib for Treatment of Relapsed/Refractory FLT3-ITD AML. Expands Use to Include Specimens Collected in EDTA - [EHATRG Clonality Interrogation by CE and NGS: Bridging the Gap Between Classical and Leading Edge Technologies - Invivoscribe](https://invivoscribe.com/trg-clonality-interrogation-by-ce-and-ngs-bridging-the-gap-between-classical-and-leading-edge-technologies/): TRG Clonality Interrogation by CE and NGS: Bridging the Gap Between Classical and Leading Edge Technologies - [32nd Japanese Society for Gene Diagnosis and Therapy - Invivoscribe](https://invivoscribe.com/32nd-japanese-society-for-gene-diagnosis-and-therapy/): Hamamatsu, Japan - [Web Privacy Policy - Invivoscribe](https://invivoscribe.com/web-privacy-policy/): It is not necessary to reveal your identity or any personal information to visit our website. - [Personalized Medicine - Invivoscribe](https://invivoscribe.com/personalized-medicine/): Personalized Molecular Medicine?ÿis use of genomics and patient specific information to identify optimal treatment for each patient. Mutations in genomic DNA drive normal cells to become cancerous. Since each cancer has a distinct genetic fingerprint, biomarker testing allows us to identify mutations - [Complementary Value of MRD Assessments by NGS and MFC for the Study of Hematologic Malignancies - Invivoscribe](https://invivoscribe.com/complementary-value-of-mrd-assessments-by-ngs-and-mfc-for-the-study-of-hematologic-malignancies/): Complementary Value of MRD Assessments by NGS and MFC for the Study of Hematologic Malignancies - [Invivoscribe Submits LeukoStrat? CDx FLT3 Mutation Assay to NMPA in China and Expands Company, Adding Laboratory in Shanghai to Provide Comprehensive Support for Partners. - Invivoscribe](https://invivoscribe.com/invivoscribe-submits-leukostrat-cdx-flt3-mutation-assay-to-nmpa-in-china-and-expands-company-adding-laboratory-in-shanghai-to-provide-comprehensive-support-for-partners/): Invivoscribe Submits LeukoStrat? CDx FLT3 Mutation Assay to NMPA in China and Expands Company, Adding Laboratory in Shanghai to Provide Comprehensive Support for Partners. - [From prognostication to precision in acute myeloid leukemia - Invivoscribe](https://invivoscribe.com/from-prognostication-to-precision-in-acute-myeloid-leukemia-2/): Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia. - [Global Standardization of Flow Cytometry Results with AI Systems - Invivoscribe](https://invivoscribe.com/global-standardization-of-flow-cytometry-results-with-ai-systems/): Global Standardization of Flow Cytometry Results with AI Systems. - [Lab Secrets: The Potential for NGS-based MRD Testing for Acute Lymphoblastic Leukemia - The Austin Experience - Invivoscribe](https://invivoscribe.com/ngs-based-mrd-testing-for-acute-lymphoblastic-leukemia/): Watch this video to find out about Invivoscribe's NGS-based MRD Testing for ALL. - [Dad hat - Invivoscribe](https://invivoscribe.com/shop/accessories/dad-hat/): Dad hats aren't just for dads. This one's got a low profile with an adjustable strap and curved visor. - [MRD Applications and Analysis](https://invivoscribe.com/mrd-applications-and-analysis/): Watch this video to find out about Multiparameter Approach to CLL Diagnosis, Prognostic Biomarker Assessment, and MRD Monitoring - [FAQ - Invivoscribe](https://invivoscribe.com/faq/): The LeukoStrat CDx FLT3 Mutation Assay is used as an aid in the assessment of patients with AML for whom RYDAPT? (midostaurin) treatment is being considered. - [NGS-based Clinical Assessment of B- and T-cell Clonality and MRD Determination - Invivoscribe](https://invivoscribe.com/ngs-based-clinical-assessment-of-b-and-t-cell-clonality-and-mrd-determination/): Watch this 20 minute video to find out about Invivoscribe's comprehensive solution for AML precision diagnostics. - [AMPA Next-Generation Sequencing Based Analysis of Clonality across 39 Subjects Treated for Lymphoproliferative Disorders Reveals Matching Clones in the Diverse IGH Locus - Invivoscribe](https://invivoscribe.com/ampa-next-generation-sequencing-based-analysis-of-clonality-across-39-subjects-treated-for-lymphoproliferative-disorders-reveals-matching-clones-in-the-diverse-igh-locus/): A Next-Generation Sequencing Based Analysis of Clonality across 39 Subjects Treated for Lymphoproliferative. Disorders Reveals Matching Clones in the Diverse IGH Locus. - [Suspect B-cell Proliferations - Invivoscribe](https://invivoscribe.com/diseases/hematological-testing-guide/suspect-b-cell-proliferations/): Suspect B-cell Proliferations - [Next-generation sequencing of immunoglobulin genes in lymphoid malignancies - Invivoscribe](https://invivoscribe.com/next-generation-sequencing-of-immunoglobulin-genes-in-lymphoid-malignancies/): Next-generation sequencing of immunoglobulin genes in lymphoid malignancies. - [Real-world data on prognostic value of measurable residual disease assessment by fragment analysis or next-generation sequencing in multiple myeloma - Invivoscribe](https://invivoscribe.com/real-world-data-on-prognostic-value-of-measurable-residual-disease-assessment-by-fragment-analysis-or-next-generation-sequencing-in-multiple-myeloma/): Real-world data on prognostic value of measurable residual disease assessment by fragment analysis or next-generation sequencing in multiple myeloma - [Mouse pad - Invivoscribe](https://invivoscribe.com/shop/accessories/mouse-pad/): Every mouse needs a good mouse pad! Our mouse pad offers supreme grip and effortless mouse movement, and it does so with style. - [Review of Guidelines for Interpreting Somatic Hypermutation Status in Chronic Lymphocytic Leukemia in the Era of High-Throughput Sequencing - Invivoscribe](https://invivoscribe.com/review-of-guidelines-for-interpreting-somatic-hypermutation-status-in-chronic-lymphocytic-leukemia-in-the-era-of-high-throughput-sequencing/): Review of Guidelines for Interpreting Somatic Hypermutation Status in Chronic Lymphocytic Leukemia in the Era of High-Throughput Sequencing - [Acute Myeloid Leukemia | Invivoscribe](https://invivoscribe.com/diseases/hematological-testing-guide/acute-myeloid-leukemia-aml-and-related-neoplasms/): Invivoscribe provides globally standardized products and services that help diagnose and monitor myeloid disorders. Learn more about our AML solutions. - [Targeted Deep Sequencing Reveals Clinically Relevant Subclonal IgHV Rearrangements in Chronic Lymphocytic Leukemia - Invivoscribe](https://invivoscribe.com/targeted-deep-sequencing-reveals-clinically-relevant-subclonal-ighv-rearrangements-in-chronic-lymphocytic-leukemia/): Targeted Deep Sequencing Reveals Clinically Relevant Subclonal IgHV Rearrangements in Chronic Lymphocytic Leukemia - [Invivoscribe Diagnostic Technologies (Shanghai) Co. Ltd. Receives CAP Accreditation to Support Clinical Research Testing for Pharmaceutical Partners in China - Invivoscribe](https://invivoscribe.com/invivoscribe-diagnostic-technologies-shanghai-co-ltd-receives-cap-accreditation-to-support-clinical-research-testing-for-pharmaceutical-partners-in-china/): Invivoscribe Diagnostic Technologies (Shanghai) Co. Ltd. Receives CAP Accreditation to Support Clinical Research Testing for Pharmaceutical Partners in China. - [A next-generation sequencing? based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations - Invivoscribe](https://invivoscribe.com/a-next-generation-sequencing-based-assay-for-minimal-residual-disease-assessment-in-aml-patients-with-flt3-itd-mutations/): A next-generation sequencing-based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations - [Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALL - Invivoscribe](https://invivoscribe.com/simple-deep-sequencing-based-post-remission-mrd-surveillance-predicts-clinical-relapse-in-b-all/): Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALL - [Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin Lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing - Invivoscribe](https://invivoscribe.com/assessment-of-bone-marrow-involvement-in-b-cell-non-hodgkin-lymphoma/): Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin Lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing - [Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma - Invivoscribe](https://invivoscribe.com/comparison-of-next-generation-sequencing-ngs-and-next-generation-flow-ngf-for-minimal-residual-disease-mrd-assessment-in-multiple-myeloma/): Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma - [Publications - Pioneering The Molecular Diagnostic Field - Invivoscribe](https://invivoscribe.com/publications/): Unlocking the full potential of personalized molecular medicine, as we know the molecular basis behind each person's disease is different. - [Unlocking the Potential of NGS Clonality and MRD Testing: From Research to High-Throughput Environments - Part 01](https://invivoscribe.com/beyond-systematic-memory-b-cell-archiving-mining-b-cell-receptor-repertoires-for-antigen-specific-clones-and-tumor-cell-precursors/): Watch this video on Beyond systematic memory B-cell archiving: Mining B-cell receptor repertoires for antigen-specific clones and tumor cell precursors. - [Invivoscribe - Trucker Cap (Version 02) - Invivoscribe](https://invivoscribe.com/shop/hats/invivoscribe-trucker-cap-version-02/): This six-panel trucker cap with a mesh back will be a comfy and classic choice for a perfect day in the sun. - [Invivoscribe - Trucker Cap (Version 01) - Invivoscribe](https://invivoscribe.com/shop/hats/invivoscribe-trucker-cap-version-01/): This six-panel trucker cap with a mesh back will be a comfy and classic choice for a perfect day in the sun. - [Breast Implant-Associated Anaplastic Large Cell Lymphoma: Two Distinct Clinicopathological Variants with Different Outcomes - Invivoscribe](https://invivoscribe.com/breast-implant-associated-anaplastic-large-cell-lymphoma-two-distinct-clinicopathological-variants-with-different-outcomes/): Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes - [Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing - Invivoscribe](https://invivoscribe.com/routine-evaluation-of-minimal-residual-disease-in-myeloma-using-next-generation-sequencing-clonality-testing/): Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing - [Comprehensive LymphoTrack MRD Solutions](https://invivoscribe.com/mrd/): Invivoscribe's Measurable or Minimal Residual Disease (MRD) monitoring using LymphoTrack enabled Ig/TR rearrangement detection. - [Mantle cell lymphoma (MCL) - Invivoscribe](https://invivoscribe.com/diseases/hematological-testing-guide/mantle-cell-lymphoma-mcl/): Diseases / Hematological Mantle cell lymphoma (MCL) - [Immunoblastic Follicular Lymphoma: A Very Unusual Transformation of Low-Grade Follicular Lymphoma - Invivoscribe](https://invivoscribe.com/immunoblastic-follicular-lymphoma-a-very-unusual-transformation-of-low-grade-follicular-lymphoma/): Immunoblastic Follicular Lymphoma: A Very Unusual Transformation of Low-Grade Follicular Lymphoma - [IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V?J and V?D?J JUNCTIONs - Invivoscribe](https://invivoscribe.com/imgt-junctionanalysis-the-first-tool-for-the-analysis-of-the-immunoglobulin-and-t-cell-receptor-complex-v-j-and-v-d-j-junctions/): IMGT/Junction Analysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V?J and V?D?J JUNCTIONs - [Invivoscribe Announces Registration of the LeukoStrat? CDx FLT3 Mutation Assay in the United Kingdom and Switzerland - Invivoscribe](https://invivoscribe.com/invivoscribe-announces-registration-of-the-leukostrat-cdx-flt3-mutation-assay-in-the-united-kingdom-and-switzerland/): Invivoscribe Announces Registration of the LeukoStrat? CDx FLT3 Mutation Assay in the United Kingdom and Switzerland - [Clinical Utility of NGS in Lymphoid Malignancies including Minimal Residual Disease (MRD) testing - Invivoscribe](https://invivoscribe.com/clinical-utility-of-ngs-in-lymphoid-malignancies-including-minimal-residual-disease-mrd-testing/): Clinical Utility of NGS in Lymphoid Malignancies including Minimal Residual Disease (MRD) testing - [Feasibility of cell-free DNA collection and clonal immunoglobulin sequencing in South African patients with HIV-associated lymphoma - Invivoscribe](https://invivoscribe.com/feasibility-of-cell-free-dna-collection-and-clonal-immunoglobulin-sequencing-in-south-african-patients-with-hiv-associated-lymphoma/): Feasibility of cell-free DNA collection and clonal immunoglobulin sequencing in South African patients with HIV-associated lymphoma - [Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessment - Invivoscribe](https://invivoscribe.com/baseline-vdj-clonotype-detection-using-a-targeted-sequencing-ngs-assay-allowing-for-subsequent-mrd-assessment/): Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessment - [Clinical-scale Rapid Autologous BK-virus Specific T Cell Line generation from Kidney Transplant Recipients with Active Viremia for Adoptive Immunotherapy - Invivoscribe](https://invivoscribe.com/clinical-scale-rapid-autologous-bk-virus-specific-t-cell-line-generation-from-kidney-transplant-recipients-with-active-viremia-for-adoptive-immunotherapy/): Clinical-scale Rapid Autologous BK-virus Specific T Cell Line generation from Kidney Transplant Recipients with Active Viremia for Adoptive Immunotherapy - [Invivoscribe To Present At Biotech Showcase? 2019 In San Francisco - Invivoscribe](https://invivoscribe.com/invivoscribe-to-present-at-biotech-showcase-2019-in-san-francisco/): Invivoscribe To Present At Biotech Showcase? 2019 In San Francisco - [Gel Detection (RUO) - FLT3, ITD, and TKD Mutation Assays](https://invivoscribe.com/products/gel-detection/ruo/): Invivoscribe products for the assessment of clonal rearrangements in patients with suspected lymphoproliferations. - [Clinical Lab Services - Internationally Standardized Testing - LabPMM - Invivoscribe](https://invivoscribe.com/clinical-lab-services/): Internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care. - [Multiparameter Approach to CLL Diagnosis, Prognostic Biomarker Assessment, and MRD Monitoring](https://invivoscribe.com/multiparameter-approach-to-cll-diagnosis-prognostic-biomarker-assessment-and-mrd-monitoring/): Watch this video to find out about Multiparameter Approach to CLL Diagnosis, Prognostic Biomarker Assessment, and MRD Monitoring. It is not necessary to reveal your identity or any personal information - [Invivoscribe Announces a Regional? Center of Excellence? Reference Laboratory in Beirut to Offer Specialized Gene Panels - Invivoscribe](https://invivoscribe.com/invivoscribe-announces-a-regional-center-of-excellence-reference-laboratory-in-beirut-to-offer-specialized-gene-panels/): Invivoscribe Announces a Regional? Center of Excellence? Reference Laboratory in Beirut to Offer Specialized Gene Panels - [Innovations in MRD Detection: Leveraging NGS to Gain Insights into Multiple Myeloma and B-ALL](https://invivoscribe.com/innovations-in-mrd-detection/): Watch this video on Beyond systematic memory B-cell archiving: Mining B-cell receptor repertoires for antigen-specific clones and tumor cell precursors. - [Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients - Invivoscribe](https://invivoscribe.com/molecular-profiling-of-immunoglobulin-heavy-chain-gene-rearrangements-unveils-new-potential-prognostic-markers-for-multiple-myeloma-patients/): Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients - [A Comprehensive Solution for AML Precision Diagnostics - Invivoscribe](https://invivoscribe.com/aml-precision-diagnostics-solution-webinar/): Watch this 20 minute video to find out about Invivoscribe's comprehensive solution for AML precision diagnostics. - [Invivoscribe Launches Grant Program to Support Novel Applications for Sequence-Based Analyses of the Immune System - Invivoscribe](https://invivoscribe.com/invivoscribe-launches-grant-program/): Invivoscribe Launches Grant Program to Support Novel Applications for Sequence-Based Analyses of the Immune System - [Invivoscribe Announces FDA Approval for Distribution of the LeukoStrat CDx FLT3 Mutation Assay as an IVD Kit in the United StatesMalignancies - Invivoscribe](https://invivoscribe.com/invivoscribe-announces-fda-approval-for-distribution-of-the-leukostrat-cdx-flt3-mutation-assay-as-an-ivd-kit-in-the-united-states/): Invivoscribe to offer the LeukoStrat? CDx FLT3 Mutation Assay as an FDA approved kit with analysis software - [Myelodysplastic syndromes (MDS) - Invivoscribe](https://invivoscribe.com/diseases/hematological-testing-guide/myelodysplastic-syndromes-mds/): Available Products & Services MyAML? 194 targeted - [AMP Evaluation of An Alternative Fragmentation Method in High Throughput NGS Sample Testing of Minimal Residual Disease in Hematological Malignancies - Invivoscribe](https://invivoscribe.com/evaluation-of-an-alternative-fragmentation-method-in-high-throughput-ngs-sample-testing-of-minimal-residual-disease-in-hematological-malignancies/): Evaluation of An Alternative Fragmentation Method in High Throughput NGS Sample Testing of Minimal Residual Disease in Hematological Malignancies - [Plasma Cell Myeloma Residual Disease Quantitation Using a Next-Generation Sequencing-Based IGH Clonal Rearrangement Assay with the Aid of a "Spike-in" Clonal Sequence - Invivoscribe](https://invivoscribe.com/plasma-cell-myeloma-residual-disease-quantitation-using-a-next-generation-sequencing-based-igh-clonal-rearrangement-assay-with-the-aid-of-a-spike-in-clonal-sequence/): Plasma Cell Myeloma Residual Disease Quantitation Using a Next-Generation Sequencing-Based IGH Clonal Rearrangement Assay with the Aid of Spike-in Clonal Sequence - [Leveraging Highly Sensitive NGS FLT3-ITD and NPM1 MRD Assessments in AML](https://invivoscribe.com/leveraging-highly-sensitive-ngs-flt3-itd-and-npm1-mrd-assessments-in-aml/): Leveraging Highly Sensitive NGS FLT3-ITD and NPM1 MRD Assessments in AML - [Invivoscribe - EHA 2019: Part 3 of 3 - Invivoscribe](https://invivoscribe.com/invivoscribe-eha-2019-part-3-of-3/): June 13th, 2019 FEATURED PRESENTERS - [Peripheral T-cell lymphoma - Invivoscribe](https://invivoscribe.com/diseases/hematological-testing-guide/peripheral-t-cell-lymphoma/): Peripheral T-cell lymphoma - [AMP - Invivoscribe](https://invivoscribe.com/amp/): Exhibiting and Hosting a Corporate Workshop - [Plasticity of the human IgM repertoire in response to long-term spaceflight - Invivoscribe](https://invivoscribe.com/plasticity-of-the-human-igm-repertoire-in-response-to-long?term-spaceflight/): Plasticity of the human IgM repertoire in response to long-term spaceflight - [Lymphoid Diseases | Invivoscribe](https://invivoscribe.com/lymphoid-diagnostic-solutions/): Invivoscribe's research and scientific collaborations drive the development of cutting-edge hematologic diagnostics. Learn about the various lymphoid diseases. - [Comparing Data Generated Using Multiparametric Flow Cytometry, Capillary Electrophoresis, and Next-Generation Sequencing in a Cohort of B-Cell Lymphoproliferative Disorder Samples - Invivoscribe](https://invivoscribe.com/comparing-data-generated-using-multiparametric-flow-cytometry-capillary-electrophoresis-and-next-generation-sequencing-in-a-cohort-of-b-cell-lymphoproliferative-disorder-samples/): Comparing Data Generated Using Multiparametric Flow Cytometry, Capillary Electrophoresis, and Next-Generation Sequencing in a Cohort of B-Cell Lymphoproliferative - [Invivoscribe - Women's Athletic T-Shirt - Invivoscribe](https://invivoscribe.com/shop/womens-clothing/invivoscribe-womens-athletic-t-shirt/): This t-shirt easily combines comfort and style - the sports mesh fabric with moisture management and anti-microbial qualities is sure to keep any athlete dry and comfortable during exercise, while the design will make it into a unique statement piece. - [Invivoscribe - Unisex Hoodie (Navy) - Invivoscribe](https://invivoscribe.com/shop/mens-clothing/invivoscribe-unisex-hoodie-navy/): Everyone needs a cozy go-to hoodie to curl up in, so go for one that's soft, smooth, and stylish. It's the perfect choice for cooler evenings! - [Invivoscribe to Participate in Virtual ASCO 2020 - Invivoscribe](https://invivoscribe.com/invivoscribe-to-participate-in-virtual-asco-2020/): Invivoscribe to Participate in Virtual ASCO 2020 - [Invivoscribe Partners with Complete Genomics to Develop and Commercialize Biomarker Tests for Oncology and Cancer Research - Invivoscribe](https://invivoscribe.com/invivoscribe-partners-with-complete-genomics-to-develop-and-commercialize-biomarker-tests-for-oncology-and-cancer-research/): Invivoscribe Partners with Complete Genomics to Develop and Commercialize Biomarker Tests for Oncology and Cancer Research - [Invivoscribe - Snapback Hat (Royal/Navy) - Invivoscribe](https://invivoscribe.com/shop/hats/invivoscribe-snapback-hat-royal-navy/): This hat is structured with a classic fit, flat brim, and full buckram. The adjustable snap closure makes it a comfortable, one-size-fits-most hat - [The Evolving Role of NGS and Measurable Residual Disease in CLL/SLL and AML](https://invivoscribe.com/evolving-role-ngs-and-mrd-in-cll/): Watch this video to find out about Multiparameter Approach to CLL Diagnosis, Prognostic Biomarker Assessment, and MRD Monitoring - [Molecular pathology diagnosis of diffuse large B cell lymphoma using BIOMED-2 clonal gene rearrangements - Invivoscribe](https://invivoscribe.com/molecular-pathology-diagnosis-of-diffuse-large-b-cell-lymphoma-using-biomed-2-clonal-gene-rearrangements/): Molecular pathology diagnosis of diffuse large B cell lymphoma using BIOMED-2 clonal gene rearrangements - [Novartis drug PKC412 (midostaurin) granted FDA Priority Review for newly-diagnosed FLT3-mutated AML and advanced systemic mastocytosis - Invivoscribe](https://invivoscribe.com/novartis-drug-pkc412-midostaurin-granted-fda-priority-review-for-newly-diagnosed-flt3-mutated-aml-and-advanced-systemic-mastocytosis/): Novartis drug PKC412 (midostaurin) granted FDA Priority Review for newly-diagnosed FLT3-mutated AML and advanced systemic mastocytosis - [Discordant Lymphoma Consisting of Mediastinal Large B-Cell Lymphoma and Nodular Sclerosis Hodgkin Lymphoma in the Right Supraclavicular Lymph Nodes: A Case Report - Invivoscribe](https://invivoscribe.com/discordant-lymphoma-consisting-of-mediastinal-large-b-cell-lymphoma-and-nodular-sclerosis-hodgkin-lymphoma-in-the-right-supraclavicular-lymph-nodes-a-case-report/): Discordant Lymphoma Consisting of Mediastinal Large B-Cell Lymphoma and Nodular Sclerosis Hodgkin Lymphoma in the Right Supraclavicular Lymph Nodes - [Invivoscribe Releases LymphoTrack? TRB Assay on MiSeq? and LymphoTrack? Minimal Residual Disease (MRD) Software - Invivoscribe](https://invivoscribe.com/invivoscribe-releases-lymphotrack-trb-assay-on-miseq-and-lymphotrack-minimal-residual-disease-mrd-software/): Invivoscribe Releases LymphoTrack? TRB Assay on MiSeq? and LymphoTrack? Minimal Residual Disease (MRD) Software - [Invivoscribe Announces IVDR Approval of the LeukoStrat CDx FLT3 Mutation Assay - Invivoscribe](https://invivoscribe.com/invivoscribe-announces-ivdr-approval-of-the-leukostrat-cdx-flt3-mutation-assay/): Invivoscribe Announces IVDR Approval of the LeukoStrat? CDxÿFLT3ÿMutation Assay - [Minimal/Measurable Residual Disease (MRD) Monitoring in Patients with Lymphoid Neoplasms by High-Throughput Sequencing of the T-Cell Receptor - Invivoscribe](https://invivoscribe.com/minimal-measurable-residual-disease-mrd-monitoring-in-patients-with-lymphoid-neoplasms-by-high-throughput-sequencing-of-the-t-cell-receptor/): Minimal/Measurable Residual Disease (MRD) Monitoring in Patients with Lymphoid Neoplasms by High-Throughput Sequencing of the T-Cell Receptor - [VIRTUAL EHA: Next Generation Analysis in CLL and Other Malignancies - Invivoscribe](https://invivoscribe.com/virtual-eha-next-generation-analysis-in-cll-and-other-malignancies/): Next Generation Analysis in CLL and Other Malignancies presented by Prof. Dr. Markus Tiemann ? Institute for Hematopathology Hamburg, Germany - [Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment - Invivoscribe](https://invivoscribe.com/pomalidomide-dexamethasone-and-daratumumab-in-relapsed-refractory-multiple-myeloma-after-lenalidomide-treatment/): Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment - [Diseases - Myeloid Overview - Invivoscribe](https://invivoscribe.com/diseases-myeloid-overview/): Invivoscribe research and scientific collaborations back the development of cutting-edge hematologic diagnostics. - [Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia - Invivoscribe](https://invivoscribe.com/measurable-residual-flt3-internal-tandem-duplication-before-allogeneic-transplant-for-acute-myeloid-leukemia/): Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia - [Clonality and Measurable Residual Disease (MRD) Testing on the Illumina NextSeq Sequencers - Invivoscribe](https://invivoscribe.com/clonality-and-measurable-residual-disease-mrd-testing-on-the-illumina-nextseq-sequencers/): Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid LeukemiaClonality and Measurable Residual Disease (MRD) Testing on the Illumina? NextSeq Sequencers - [DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant - Invivoscribe](https://invivoscribe.com/dna-sequencing-to-detect-residual-disease-in-adults-with-acute-myeloid-leukemia-prior-to-hematopoietic-cell-transplant/): DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant - [Invivoscribe - Men's Embroidered Polo Shirt (Version 01) - Invivoscribe](https://invivoscribe.com/shop/mens-clothing/invivoscribe-mens-embroidered-polo-shirt-version-01/): Combine style and class with this 100% cotton polo shirt! The detailed embroidery is a great conversation starter, and thanks to the pre-shrunk fabric, the shirt will maintain its shape after washing. - [Accelerate MRD Testing - Invivoscribe](https://invivoscribe.com/acceleratemrdtesting/): Invivoscribe can help you build a powerful NGS MRD solution for your lab. - [Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell Neoplasms - Invivoscribe](https://invivoscribe.com/establishment-of-immunoglobulin-heavy-igh-chain-clonality-testing-by-next-generation-sequencing-for-routine-characterization-of-b-cell-and-plasma-cell-neoplasms/): Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell - [Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapy - Invivoscribe](https://invivoscribe.com/immune-recovery-in-patients-with-mantle-cell-lymphoma-receiving-long-term-ibrutinib-and-venetoclax-combination-therapy/): Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapy - [Invivoscribe files sPMA with the FDA for use of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with Newly Diagnosed FLT3-ITD Positive AML - Invivoscribe](https://invivoscribe.com/invivoscribe-files-spma-with-the-fda-for-use-of-the-leukostrat-cdx-flt3-mutation-assay-to-select-patients-with-newly-diagnosed-flt3-itd-positive-aml/): Invivoscribe files sPMA with the FDA for use of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with Newly Diagnosed FLT3-ITD Positive AML - [Mug - Invivoscribe](https://invivoscribe.com/shop/home-living/mug/): Whether you're drinking your morning coffee, evening tea, or something in between ? this mug's for you! It's sturdy and glossy with a vivid print that'll withstand the microwave and dishwasher. - [Controls - Plasmid DNA, DNA, RNA Extracted From Cell Lines](https://invivoscribe.com/products/controls/): Invivoscribe offers an extensive range of General Purpose Reagents (GPRs) and Research Use Only (RUO) controls. - [Novartis drug PKC412 (midostaurin) improves overall survival by 23% in global Phase III study of AML patients with FLT3 mutations - Invivoscribe](https://invivoscribe.com/novartis-drug-pkc412-midostaurin-improves-overall-survival-by-23-in-global-phase-iii-study-of-aml-patients-with-flt3-mutations/): Novartis drug PKC412 (midostaurin) improves overall survival by 23% in global Phase III study of AML patients with FLT3 mutations - [Invivoscribe - Women's Joggers (Version 01) - Invivoscribe](https://invivoscribe.com/shop/womens-clothing/invivoscribe-womens-joggers-version-01/): Get ready for that 10K run or take it slow in your backyard?these joggers are sure to make you feel comfortable either way. - [Upgraded Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma - Invivoscribe](https://invivoscribe.com/upgraded-standardized-minimal-residual-disease-detection-by-next-generation-sequencing-in-multiple-myeloma/): Upgraded Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma - [Immunoglobulin gene rearrangement in Koreans with multiple myeloma: Clonality assessment and repertoire analysis using next-generation sequencing - Invivoscribe](https://invivoscribe.com/immunoglobulin-gene-rearrangement-in-koreans/): Immunoglobulin gene rearrangement in Koreans with multiple myeloma: Clonality assessment and repertoire analysis using next-generation sequencing - [Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma - Invivoscribe](https://invivoscribe.com/standardized-minimal-residual-disease-detection-by-next-generation-sequencing-in-multiple-myeloma/): Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma - [NOW AVAILABLE! MRD solutions for B- and T-cell clonality tracking - Invivoscribe](https://invivoscribe.com/now-available-mrd-solutions-for-b-and-t-cell-clonality-tracking/): NOW AVAILABLE! MRD solutions for B- and T-cell clonality tracking - [Measurable residual disease and post-transplantation gilteritinib maintenance for patients with FLT3 ITD mutated AML - Invivoscribe](https://invivoscribe.com/measurable-residual-disease-and-posttransplantation-gilteritinib-maintenance-for-patients-with-flt3-itd-mutated-aml/): Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia - [MRD Software Help - Invivoscribe](https://invivoscribe.com/mrd-software-help/): A1?In version 2.0.1 of the LymphoTrack MRD Software, the average of all replicates is now displayed instead of the replicate with the highest read frequency as in previous versions of the software. - [Molecular Diagnostics of Hematologic Malignancies - Invivoscribe](https://invivoscribe.com/molecular-diagnostics-of-hematologic-malignancies/): Molecular Diagnostics of Hematologic Malignancies - [Quantitation of CMV Specific T-Cell Expansion Using T Cell Receptor Beta Locus Deep Sequencing to Identify Patients at Risk of Viral Complications - Invivoscribe](https://invivoscribe.com/quantitation-of-cmv-specific-t-cell-expansion-using-t-cell-receptor-beta-locus-deep-sequencing-to-identify-patients-at-risk-of-viral-complications/): Quantitation of CMV Specific T-Cell Expansion Using T Cell Receptor Beta Locus Deep Sequencing to Identify Patients at Risk of Viral Complications - [Level Up Your MRD Testing: Leveraging Standardized & Sensitive AML Assessments](https://invivoscribe.com/level-up-your-mrd-testing-video/): Watch this video to find out how to leverage standardized & sensitive AML assessments to level up your MRD testing - [EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations - Invivoscribe](https://invivoscribe.com/euroclonality-biomed-2-guidelines-for-interpretation-and-reporting-of-ig-tcr-clonality-testing-in-suspected-lymphoproliferations/): EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations - [We are Invivoscribe - Company Overview - Invivoscribe](https://invivoscribe.com/we-are-invivoscribe-company-overview/): Watch this video to find out about Invivoscribe's NGS-based MRD Testing for ALL - [T-Cell Large Granular Lymphocytic Leukemia (T-LGL Leukemia) - Invivoscribe](https://invivoscribe.com/diseases/hematological-testing-guide/t-cell-large-granular-lymphocytic-leukemia-t-lgl-leukemia/): Diseases / Hematological Testing Guide / T-Cell Large Granular Lymphocytic Leukemia (T-LGL Leukemia) - [Invivoscribe Expanding Clinical Laboratory Network Space and Testing Capabilities in San Diego, Germany, Japan, and China. Offering Comprehensive Standardized Testing for All Hematologic Malignancies - Invivoscribe](https://invivoscribe.com/invivoscribe-expanding-clinical-laboratory-network-space-and-testing-capabilities-in-san-diego-germany-japan-and-china-offering-comprehensive-standardized-testing-for-all-hematologic-malignancies/): Invivoscribe Expanding Clinical Laboratory Network Space and Testing Capabilities in San Diego, Germany, Japan, and China. Offering Comprehensive Standardized Testing for All Hematologic Malignancies - [Invivoscribe - Premium Face Mask (Royal) - Invivoscribe](https://invivoscribe.com/shop/accessories/premium-face-mask/): This reusable face mask will fit you nicely thanks to its adjustable nose wire and elastic bands. Choose a design that will complement your style, as face masks are becoming the new trend. - [EU Notified Body (BSI Netherlands) and the EMA Grant Approval of the LeukoStrat? CDx FLT3 Mutation Assay for VANFLYTA? Therapy in the EU and EEA - Invivoscribe](https://invivoscribe.com/eu-notified-body-bsi-netherlands-and-the-ema-grant-approval-of-the-leukostrat-cdx-flt3-mutation-assay-for-vanflyta-therapy-in-the-eu-and-eea/): EU Notified Body (BSI Netherlands) and the EMA Grant Approval of the LeukoStrat? CDx FLT3 Mutation Assay for VANFLYTA? Therapy in the EU and EEA - [Deep sequencing reveals clonal evolution patterns and mutation associated with relapse in B-cell lymphomas - Invivoscribe](https://invivoscribe.com/deep-sequencing-reveals-clonal-evolution-patterns-and-mutation-events-associated-with-relapse-in-b-cell-lymphomas/): Deep sequencing reveals clonal evolution patterns and mutation associated with relapse in B-cell lymphomas - [Molecular Genetic Data Favoring a Sequential Clonal Transformation of a Large B Cell Lymphoma into an Anaplastic Large T Cell Lymphoma, ALK-Negative - Invivoscribe](https://invivoscribe.com/molecular-genetic-data-favoring-a-sequential-clonal-transformation-of-a-large-b-cell-lymphoma-into-an-anaplastic-large-t-cell-lymphoma-alk-negative/): Molecular Genetic Data Favoring a Sequential Clonal Transformation of a Large B Cell Lymphoma into an Anaplastic Large T Cell Lymphoma, ALK-Negative - [Lab Secrets: Stratification and Prognoses of Leukemia and Multiple Myeloma using Next-Generation Sequencing (NGS) - Invivoscribe](https://invivoscribe.com/lab-secrets-stratification-and-prognoses-of-leukemia-and-multiple-myeloma-using-next-generation-sequencing-ngs/): Invivoscribe is a technology-driven international company focused on precision diagnostics with best-in-class products and services that optimize patient care and accelerate drug - [Invivoscribe-iPhone Case (Version 01) - Invivoscribe](https://invivoscribe.com/shop/accessories/invivoscribe-iphone-case-version-01/): This sleek iPhone case protects your phone from scratches, dust, oil, and dirt. It has a solid back and flexible sides that make it easy to take on and off, with precisely aligned port openings. - [Invivoscribe-iPhone Case (Version 02) - Invivoscribe](https://invivoscribe.com/shop/accessories/invivoscribe-iphone-case-version-02/): This sleek iPhone case protects your phone from scratches, dust, oil, and dirt. It has a solid back and flexible sides that make it easy to take on and off, with precisely aligned port openings. - [German Supreme Court Upholds and Strengthens Invivoscribe FLT3 Patent Position - Invivoscribe](https://invivoscribe.com/german-supreme-court-upholds-and-strengthens-invivoscribe-flt3-patent-position/): German Supreme Court Upholds and Strengthens Invivoscribe FLT3 Patent Position - [Chronic lymphocytic leukemia (CLL) - Invivoscribe](https://invivoscribe.com/diseases/hematological-testing-guide/chronic-lymphocytic-leukemia-cll/): Chronic lymphocytic leukemia (CLL) - [Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing?Based Clonality Testing in B-Cell and Plasma Cell Neoplasms - Invivoscribe](https://invivoscribe.com/quantification-of-measurable-residual-disease-detection-by-next-generation-sequencing-based-clonality-testing-in-b-cell-and-plasma-cell-neoplasms/): Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing?Based Clonality Testing in B-Cell and Plasma Cell Neoplasms - [Invivoscribe - Unisex Long Sleeve Shirt - Invivoscribe](https://invivoscribe.com/shop/mens-clothing/invivoscribe-unisex-long-sleeve-shirt/): A good long-sleeved shirt is a men's fashion must-have. Add this wardrobe essential to your collection, and have a great to-go option for a casual look, or a relaxed business outfit. - [Follicular lymphoma - Invivoscribe](https://invivoscribe.com/diseases/hematological-testing-guide/follicular-lymphoma/): Follicular lymphoma - [Invivoscribe - Beach Towel (Version 03) - Invivoscribe](https://invivoscribe.com/shop/home-living/invivoscribe-beach-towel-version-03/): Give your bathroom a vibrant look and wrap yourself up with this super soft and cozy all-over sublimation towel. - [Invivoscribe - Beach Towel (Version 01) - Invivoscribe](https://invivoscribe.com/shop/home-living/invivoscribe-beach-towel-version-01/): Give your bathroom a vibrant look and wrap yourself up with this super soft and cozy all-over sublimation towel. - [Invivoscribe - Beach Towel (Version 02) - Invivoscribe](https://invivoscribe.com/shop/home-living/invivoscribe-beach-towel-version-02/): Give your bathroom a vibrant look and wrap yourself up with this super soft and cozy all-over sublimation towel. - [NGS Assessment of SHM in CLL/SLL: A Practical Comparison of Platforms and Primers](https://invivoscribe.com/ngs-assessment-of-shm-in-cll-sll-a-practical-comparison-of-platforms-and-primers/): Watch this video to find out about Multiparameter Approach to CLL Diagnosis, Prognostic Biomarker Assessment, and MRD Monitoring - [Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing - Invivoscribe](https://invivoscribe.com/validation-of-a-next-generation-sequencing-based-t-cell-receptor-gamma-gene-rearrangement-diagnostic-assay-transitioning-from-capillary-electrophoresis-to-next-generation-sequencing/): Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing - [Critical Mistakes to Avoid when Developing a Drug/CDx Combination for International Registrations - Invivoscribe](https://invivoscribe.com/critical-mistakes-to-avoid-when-developing-a-drug-cdx-combination-for-international-registrations/): Critical Mistakes to Avoid when Developing a Drug/CDx Combination for International Registrations - [Invivoscribe - Navy Blue Unisex Hoodie - Invivoscribe](https://invivoscribe.com/shop/womens-clothing/womens-navy-unisex-hoodie/): A soft and comfy unisex hoodie that fits all your hoodie needs. The fleece fabric makes it a great partner all year round, be it a summer evening on the beach, or a Christmas dinner in a mountain cabin. - [LymphoTrack MRD NGS | Invivoscribe](https://invivoscribe.com/mrd-clonality/): Invivoscribe's measurable or minimal residual disease (MRD) monitoring uses highly sensitive LymphoTrack-enabled Ig/TR rearrangement detection. Learn more. - [Invivoscribe Appoints Masato Sasaki as General Manager of LabPMM, GK (Japan) - Invivoscribe](https://invivoscribe.com/invivoscribe-appoints-masato-sasaki-as-general-manager-of-labpmm-gk-japan/): Invivoscribe Appoints Masato Sasaki as General Manager of LabPMM, GK (Japan) - [Detection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic Leukemia - Invivoscribe](https://invivoscribe.com/detection-of-immunoglobulin-heavy-chain-gene-clonality-by-next-generation-sequencing-for-minimal-residual-disease-monitoring-in-b-lymphoblastic-leukemia/): Detection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic - [LabPMM Receives New York State Approval for the NPM1 MRD Assay - Informing Therapy and Accelerating Targeted Trials - Invivoscribe](https://invivoscribe.com/labpmm-receives-new-york-state-approval-for-the-npm1-mrd-assay-informing-therapy-and-accelerating-targeted-trials/): LabPMM Receives New York State Approval for the NPM1 MRD Assay - Informing Therapy and Accelerating Targeted Trial - [Precision Diagnostics | Invivoscribe](https://invivoscribe.com/): Invivoscribe is an industry pioneer in precision diagnostics offering superior-quality assays, reagents, and laboratory services worldwide. Contact us today! - [Companion Diagnostics (CDx) - LeukoStrat CDx FLT3 Mutation Assays](https://invivoscribe.com/products/companion-diagnostics-cdx/): Invivoscribe's solution for FLT3 ITD & TKD detection allows laboratories and physicians to support patients with high-quality, diagnostics. - [A Streamlined Laboratory Workflow for Controlling Antibody and Reagent Lots on a 12C Flow Cytometry System - Invivoscribe](https://invivoscribe.com/a-streamlined-laboratory-workflow-for-controlling-antibody-and-reagent-lots-on-a-12c-flow-cytometry-system/): A Streamlined Laboratory Workflow for Controlling Antibody and Reagent Lots on a 12C Flow Cytometry System - [Leveraging Highly Sensitive NGS Assays for Clonality, SHM and MRD Assessments](https://invivoscribe.com/leveraging-highly-sensitive-ngs-assays-for-clonality-shm-and-mrd-assessments/): Leveraging Highly Sensitive NGS Assays for Clonality, SHM and MRD Assessments - [Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma - Invivoscribe](https://invivoscribe.com/clonal-characterization-and-somatic-hypermutation-assessment-by-next-generation-sequencing-in-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma/): Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma - [Newsroom - Best in Class Assays, Reagents and Clinical Lab Services - Invivoscribe](https://invivoscribe.com/newsroom/): Invivoscribe is an industry pioneer with experience developing and manufacturing diagnostic products and reagents for leukemias and lymphomas. - [JSPHO Annual Meeting - Invivoscribe](https://invivoscribe.com/jspho-annual-meeting/): Attending - [Performance Comparison of Invivoscribe?s LymphoTrack? Assays Between Complete Genomics DNBSEQ-G99 and Illumina? MiSeqTM NGS Platforms - Invivoscribe](https://invivoscribe.com/performance-comparison-of-invivoscribes-lymphotrack-assays-between-complete-genomics-dnbseq-g99-and-illumina-miseqtm-ngs-platforms/): Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid LeukemiaClonality and Measurable Residual Disease (MRD) Testing on the Illumina? NextSeq Sequencers - [Invivoscribe?s LabPMM Gains New York State Approval for the FLT3 ITD MRD Assay - Invivoscribe](https://invivoscribe.com/invivoscribes-labpmm-gains-new-york-state-approval-for-the-flt3-itd-mrd-assay/): Invivoscribe?s LabPMM Gains New York State Approval for the FLT3 ITD MRD Assay - [Diagnostic Utility of a Clonality Test for Lymphoproliferative Diseases in Koreans Using the BIOMED-2 PCR Assay - Invivoscribe](https://invivoscribe.com/diagnostic-utility-of-a-clonality-test-for-lymphoproliferative-diseases-in-koreans-using-the-biomed-2-pcr-assay/): Diagnostic Utility of a Clonality Test for Lymphoproliferative Diseases in Koreans Using the BIOMED-2 PCR Assay - [Ig Gene Clonality Analysis Using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma Patients - Invivoscribe](https://invivoscribe.com/ig-gene-clonality-analysis-using-next-generation-sequencing-for-improved-minimal-residual-disease-detection-with-significant-prognostic-value-in-multiple-myeloma-patients/): Ig Gene Clonality Analysis Using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma Patients - [Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia - Invivoscribe](https://invivoscribe.com/immunoglobulin-transcript-sequence-and-somatic-hypermutation-computation-from-unselected-rna-seq-reads-in-chronic-lymphocytic-leukemia/): Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia - [Invivoscribe Premieres 12-Color Flow Cytometry Capabilities at their Reference Labs in the US, Europe, and China - Invivoscribe](https://invivoscribe.com/invivoscribe-premieres-12-color-flow-cytometry-capabilities/): Invivoscribe Premieres 12-Color Flow Cytometry Capabilities at their Reference Labs in the US, Europe, and China - [Diffuse large B-cell lymphoma (DLBCL), NOS - Invivoscribe](https://invivoscribe.com/diseases/hematological-testing-guide/diffuse-large-b-cell-lymphoma-dlbcl-nos/): Diffuse large B-cell lymphoma (DLBCL), NOS - [Monitoring minimal residual disease in the bone marrow using next generation sequencing - Invivoscribe](https://invivoscribe.com/monitoring-minimal-residual-disease-in-the-bone-marrow-using-next-generation-sequencing/): Monitoring minimal residual disease in the bone marrow using next generation sequencing - [Invivoscribe - Premium Face Mask (Navy) - Invivoscribe](https://invivoscribe.com/shop/accessories/invivoscribe-premium-face-mask-navy/): This reusable face mask will fit you nicely thanks to its adjustable nose wire and elastic bands. Choose a design that will complement your style, as face masks are becoming the new trend. - [High-Throughput Sequencing of TCR Gene Rearrangements as a Useful Tool for Identifying and Tracking Minimal/Measurable Residual Disease (MRD) in Lymphoid Malignancies - Invivoscribe](https://invivoscribe.com/high-throughput-sequencing-of-tcr-gene-rearrangements-as-a-useful-tool-for-identifying-and-tracking-minimal-measurable-residual-disease-mrd-in-lymphoid-malignancies/): Watch this video to find out about Invivoscribe's NGS-based MRD Testing for ALL - [Invivoscribe - Hat (Version 02) - Invivoscribe](https://invivoscribe.com/shop/hats/invivoscribe-hat-version-02/): Dad hats aren't just for dads. This one's got a low profile with an adjustable strap and curved visor. - [Invivoscribe - Hat (Version 01) - Invivoscribe](https://invivoscribe.com/shop/hats/invivoscribe-hat-version-01/): Dad hats aren't just for dads. This one's got a low profile with an adjustable strap and curved visor. - [Lymphoid & Myeloid Diagnostic Solutions | Invivoscribe](https://invivoscribe.com/diseases/): Invivoscribe research and scientific collaborations back the development of cutting-edge hematologic diagnostics. - [T-Cell Prolymphocytic Leukemia (T-PLL) - Invivoscribe](https://invivoscribe.com/diseases/hematological-testing-guide/t-cell-prolymphocytic-leukemia-t-pll/): T-Cell Prolymphocytic Leukemia (T-PLL - [Science - Molecular Diagnostics and Personalized Molecular Medicine - Invivoscribe](https://invivoscribe.com/science-overview/): Invivoscribe is committed to providing high-quality, reliable, cutting-edge tools and diagnostic solutions for all hematological diseases. - [NGS Grant - Invivoscribe](https://invivoscribe.com/ngs-grant/): Invivoscribe is pleased to announce a call for entries for our first Immune Biomarker Discovery grant program. The Invivoscribe grant program aims to empower - [Minimal Residual Disease (MRD) Status Following Induction Chemo-Immunotherapy Predicts Progression-Free Survival In Mantle Cell Lymphoma (MCL): CALGB 50403 (Alliance) - Invivoscribe](https://invivoscribe.com/minimal-residual-disease-mrd-status-following-induction-chemo-immunotherapy-predicts-progression-free-survival-in-mantle-cell-lymphoma-mcl-calgb-50403-alliance/): Minimal Residual Disease (MRD) Status Following Induction Chemo-Immunotherapy Predicts Progression-Free Survival In Mantle Cell Lymphoma (MCL) - [Invivoscribe - Navy Blue Unisex T-Shirt - Invivoscribe](https://invivoscribe.com/shop/mens-clothing/invivoscribe-short-sleeve-unisex-t-shirt/): You've now found the staple t-shirt of your wardrobe. It's made of a thicker, heavier cotton, but it's still soft and comfy. And the double stitching on the neckline and sleeves add more durability to what is sure to be a favorite! - [Mucosal CD30-Positive T-Cell Lymphoproliferative Disorder Arising in the Oral Cavity Following Dental Implants - Invivoscribe](https://invivoscribe.com/mucosal-cd30-positive-t-cell-lymphoproliferative-disorder-arising-in-the-oral-cavity-following-dental-implants/): Mucosal CD30-Positive T-Cell Lymphoproliferative Disorder Arising in the Oral Cavity Following Dental Implants - [Clinical Utility of NGS in Lymphoid Malignancies - Invivoscribe](https://invivoscribe.com/clinical-utility-of-ngs-in-lymphoid-malignancies/): Clinical Utility of NGS in Lymphoid Malignancies - [Invivoscribe to Exhibit at 25th EHA Annual Congress - Invivoscribe](https://invivoscribe.com/invivoscribe-to-exhibit-at-25th-eha-annual-congress/): Invivoscribe to Exhibit at 25th EHA Annual Congress - [Biobank Repository - Invivoscribe](https://invivoscribe.com/biobank-repository/): Invivoscribe research and scientific collaborations back the development of cutting-edge hematologic diagnostics. - [Invivoscribe - Samsung Case (Version 01) - Invivoscribe](https://invivoscribe.com/shop/accessories/invivoscribe-samsung-case-version-01/): This sleek Samsung case protects your phone from scratches, dust, oil, and dirt. It has a solid back and flexible sides that make it easy to take on and off, with precisely aligned cuts and holes. - [Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML - Invivoscribe](https://invivoscribe.com/kronos-bio-and-invivoscribe-partner-on-companion-diagnostic/): Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML - [Our Mission, Vision & Values](https://invivoscribe.com/mission-vision-values/): Invivoscribe offers oncology testing products, services, B- and T-cell clonality, NGS gene panels, MRD assays, and bioinformatics software. - [Invivoscribe - Samsung Case (Version 02) - Invivoscribe](https://invivoscribe.com/shop/accessories/invivoscribe-samsung-case-version-02/): This sleek Samsung case protects your phone from scratches, dust, oil, and dirt. It has a solid back and flexible sides that make it easy to take on and off, with precisely aligned cuts and holes. - [Validation and interpretation of IGH and TCR clonality testing by Ion Torrent S5 NGS for diagnosis and disease monitoring in B and T cell cancers - Invivoscribe](https://invivoscribe.com/validation-and-interpretation-of-igh-and-tcr-clonality-testing-by-ion-torrent-s5-ngs-for-diagnosis-and-disease-monitoring-in-b-and-t-cell-cancers/): Validation and interpretation of IGH and TCR clonality testing by Ion Torrent S5 NGS for diagnosis and disease monitoring in B and T cell cancer - [Invivoscribe - Throw Blanket (Version 01) - Invivoscribe](https://invivoscribe.com/shop/home-living/invivoscribe-throw-blanket-version-01/): Do you feel that your home is missing an eye-catching, yet practical design element? Solve this problem with a soft silk touch throw blanket that's ideal for lounging on the couch during chilly evenings. - [Invivoscribe - Throw Blanket (Version 02) - Invivoscribe](https://invivoscribe.com/shop/home-living/invivoscribe-throw-blanket-version-02/): Do you feel that your home is missing an eye-catching, yet practical design element? Solve this problem with a soft silk touch throw blanket that's ideal for lounging on the couch during chilly evenings. - [Contact Us - Generating Clinically Actionable Results That Optimize Treatments - Invivoscribe](https://invivoscribe.com/contact/): Invivoscribe and LabPMM General Inquiries, Customer Support, Technical Support and Global Distributors Contact. - [Next-Generation Sequencing (CE-IVD) - Powerful DNA Sequencing Assays](https://invivoscribe.com/products/ngs/ce-ivd/): Developed for use with Illumina MiSeq & Thermo Fisher Ion S5/PGM. NGS allows for massively parallel sequencing of millions of DNA fragments. - [Hitachi High-Tech and Invivoscribe partner to advance molecular diagnostics and precision medicine - Invivoscribe](https://invivoscribe.com/hitachi-high-tech-and-invivoscribe-partner-to-advance-molecular-diagnostics-and-precision-medicine/): Hitachi High-Tech and Invivoscribe partner to advance molecular diagnostics and precision medicine - [ABI Fluorescence Detection (RUO) - PCR-Based Molecular Testing](https://invivoscribe.com/products/abi-fluorescence-detection/ruo/): Detection, assessment and monitoring of point mutations, internal tandem duplications, and chromosomal aberrations. - [Ion Torrent Developers Alliance Program Designed to Speed Targeted NGS Assay Development - Invivoscribe](https://invivoscribe.com/ion-torrent-developers-alliance-program-designed-to-speed-targeted-ngs-assay-development/): Ion Torrent Developers Alliance Program Designed to Speed Targeted NGS Assay Development - [Development and Implementation of an Automated and Highly Accurate Reporting Process for NGS-based Clonality Testing - Invivoscribe](https://invivoscribe.com/development-and-implementation-of-an-automated-and-highly-accurate-reporting-process-for-ngs-based-cloanlity-testing/): Watch this video to find out about Invivoscribe's NGS-based MRD Testing for ALL - [Immunoglobulin Heavy Chain High-Throughput Sequencing in Pediatric B-Precursor Acute Lymphoblastic Leukemia: Is the Clonality of the Disease at Diagnosis Related to Its Prognosis? - Invivoscribe](https://invivoscribe.com/immunoglobulin-heavy-chain-high-throughput-sequencing-in-pediatric-b-precursor-acute-lymphoblastic-leukemia-is-the-clonality-of-the-disease-at-diagnosis-related-to-its-prognosis/): Immunoglobulin Heavy Chain High-Throughput Sequencing in Pediatric B-Precursor Acute Lymphoblastic Leukemia: Is the Clonality of the Disease at Diagnosis Related to Its Prognosis? - [Corporate Overview - Invivoscribe](https://invivoscribe.com/improving-lives-with-precision-diagnostics/): Invivoscribe is a technology-driven international company focused on precision diagnostics with best-in-class products and services that optimize patient care and accelerate drug approvals worldwide. - [Invivoscribe Submits LeukoStrat CDx FLT3 Mutation Assay both in the US and Japan to Support Daiichi Sankyo Submissions for Quizartinib - Invivoscribe](https://invivoscribe.com/invivoscribe-submits-leukostrat-cdx-flt3-mutation-assay-both-in-the-us-and-japan-to-support-daiichi-sankyo-submissions-for-quizartinib/): Invivoscribe Submits LeukoStrat CDx FLT3 Mutation Assay both in the US and Japan to Support Daiichi Sankyo Submissions for Quizartinib - [Invivoscribe ? ASCO ? LeukoStrat CDx FLT3 Mutation Assay - Invivoscribe](https://invivoscribe.com/invivoscribe-asco-leukostrat-cdx-flt3-mutation-assay/): Invivoscribe ? ASCO ? LeukoStrat CDx FLT3 Mutation Assay - [Plasma cell myeloma (Multiple Myeloma) - Invivoscribe](https://invivoscribe.com/diseases/hematological-testing-guide/plasma-cell-myeloma-multiple-myeloma/): Plasma cell myeloma (Multiple Myeloma) - [Marginal zone lymphoma - Invivoscribe](https://invivoscribe.com/diseases/hematological-testing-guide/marginal-zone-lymphoma/): Marginal zone lymphoma - [Classification of intestinal T-cell receptor repertoires using machine learning methods can identify patients with coeliac disease regardless of dietary gluten status - Invivoscribe](https://invivoscribe.com/classification-of-intestinal-t?cell-receptor-repertoires-using-machine-learning-methods-can-identify-patients-with-coeliac-disease-regardless-of-dietary-gluten-status/): Classification of intestinal T-cell receptor repertoires using machine learning methods can identify patients with coeliac disease regardless of dietary gluten status - [Machine Learning Algorithms Accelerate Throughput of a Flow - Sequencing Cell Based Assay for an Acute Myeloid Leukemia (AML) Therapeutic Discovery Platform - Invivoscribe](https://invivoscribe.com/machine-learning-algorithms-accelerate-throughput-of-a-flow-sequencing-cell-based-assay-for-an-acute-myeloid-leukemia-aml-therapeutic-discovery-platform/): Machine Learning Algorithms Accelerate Throughput of a Flow - Sequencing Cell Based Assay for an Acute Myeloid Leukemia (AML) Therapeutic Discovery Platform - [Invivoscribe? Receives FDA Approval for the LeukoStrat? CDx FLT3 Mutation Assay Companion Diagnostic Test for the Selection of Patients for Rydapt? and is the First Companion Diagnostic for AML - Invivoscribe](https://invivoscribe.com/invivoscribe-receives-fda-approval-for-the-leukostrat-cdx-flt3-mutation-assay-companion-diagnostic-test-for-the-selection-of-patients-for-rydapt-and-is-the-first-companion-diagnostic/): Invivoscribe? Receives FDA Approval for the LeukoStrat? CDx FLT3 Mutation Assay Companion Diagnostic Test for the Selection of Patients for Rydapt? and is the First Companion Diagnostic for AML - [Grant Application - Invivoscribe](https://invivoscribe.com/grant-application/): The grant proposal must be in the field of human healthy Upon project completion, the grant winner and runner-ups agree to participate in at least one of the following activities relating to the specific project, with - [Dried Blood Spot Sampling for Detection of Monoclonal Immunoglobulin Gene Rearrangement - Invivoscribe](https://invivoscribe.com/dried-blood-spot-sampling-for-detection-of-monoclonal-immunoglobulin-gene-rearrangement/): Dried Blood Spot Sampling for Detection of Monoclonal Immunoglobulin Gene Rearrangement - [Next-Generation Sequencing (RUO) - DNA Sequencing Technology](https://invivoscribe.com/products/ngs/ruo/): Developed for use with Thermo Fisher Ion S5/PGM & Illumina MiSeq. NGS allows for massively parallel sequencing of millions of DNA fragments. - [Lymphoid and Myeloid Hematological Testing Menu | Invivoscribe](https://invivoscribe.com/diseases/hematological-testing-guide-old/): Browse our comprehensive lymphoid and myeloid hematological menu of product & testing services. - [Primary non-Hodgkin lymphoma of the tongue base: the clinicopathology of seven cases and evaluation of HPV and EBV status - Invivoscribe](https://invivoscribe.com/primary-non-hodgkin-lymphoma-of-the-tongue-base-the-clinicopathology-of-seven-cases-and-evaluation-of-hpv-and-ebv-status/): Primary non-Hodgkin lymphoma of the tongue base: the clinicopathology of seven cases and evaluation of HPV and EBV status - [Reagents - Analyte Specific Reagents (ASRs), Enzymes, Hi-Di Formamide](https://invivoscribe.com/products/reagents/): Invivoscribe's ASRs targeting FLT3 ITD, FLT3 TKD, B- and T-cell antigen receptor loci, IGH-BCL2, BCR-ABL1, and PML-RARà. - [Comparison of Complete Genomics DNBSEQ-G99 Sequencer and Illumina? MiSeqTM using Invivoscribe?s FLT3 ITD MRD Assay and NPM1 MRD Assay - Invivoscribe](https://invivoscribe.com/comparison-of-complete-genomics-dnbseq-g99a-sequencer-and-illumina-miseqtm-using-invivoscribes-flt3-itd-mrd-assay-and-npm1-mrd-assay/): Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid LeukemiaClonality and Measurable Residual Disease (MRD) Testing on the Illumina? NextSeq Sequencers - [Company - Experts in Molecular Products and Services For Oncology Testing - Invivoscribe](https://invivoscribe.com/company/): We are the foremost experts in providing molecular products and services for oncology testing. Invivoscribe offers a full range of oncology testing products and services (B- and T-cell clonality, NGS - [Paediatric and Adolescent Elevated Conjunctival Lesions in the Plical Area: Lymphoma or Reactive Lymphoid Hyperplasia? - Invivoscribe](https://invivoscribe.com/paediatric-and-adolescent-elevated-conjunctival-lesions-in-the-plical-area-lymphoma-or-reactive-lymphoid-hyperplasia/): Paediatric and Adolescent Elevated Conjunctival Lesions in the Plical Area: Lymphoma or Reactive Lymphoid Hyperplasia? - [IMGT/GeneInfo: T cell receptor gamma TRG and delta TRD genes in database give access to all TR potential V(D)J recombinations - Invivoscribe](https://invivoscribe.com/imgt-geneinfo-t-cell-receptor-gamma-trg-and-delta-trd-genes-in-database-give-access-to-all-tr-potential-vdj-recombinations/): IMGT/GeneInfo: T cell receptor gamma TRG and delta TRD genes in database give access to all TR potential V(D)J recombinations - [US FDA approves Invivoscribe LeukoStrat CDx FLT3 Mutation Assay as CDx and Astellas drug XOSPATA (gilteritinib fumarate) for treatment of AML patients in the USInvivoscribe also Receives National Reimbursement for CDx Assay in Japan - Invivoscribe](https://invivoscribe.com/us-fda-approves-invivoscribe-leukostrat-cdx-flt3-mutation-assay-as-cdx-and-astellas-drug-xospata-gilteritinib-fumarate-for-treatment-of-aml-patients-in-the-us/): US FDA approves Invivoscribe LeukoStrat CDx FLT3 Mutation Assay as CDx and Astellas drug XOSPATA (gilteritinib fumarate) for treatment of AML patients in the US - [VIRTUAL EHA: Clonality analysis with NGS is the new frontier in MRD detection - Invivoscribe](https://invivoscribe.com/virtual-eha-clonality-analysis-with-ngs-is-the-new-frontier-in-mrd-detection/): Clonality analysis with NGS is the new frontier in MRD detection presented by Prof. Sara Galimberti - University of Pisa, Department of Clinical - [Genetic evolution of in situ follicular neoplasia to aggressive B-cell lymphoma of germinal center subtype - Invivoscribe](https://invivoscribe.com/genetic-evolution-of-in-situ-follicular-neoplasia-to-aggressive-b-cell-lymphoma-of-germinal-center-subtype/): Genetic evolution of in situ follicular neoplasia to aggressive B-cell lymphoma of germinal center subtype - [Invivoscribe - Vintage Cotton Twill Cap (Version 01) - Invivoscribe](https://invivoscribe.com/shop/hats/invivoscribe-vintage-cotton-twill-cap-version-01/): Everybody knows that dad caps are no longer just for dads, so get an embroidered cotton twill cap for yourself! This one's really special thanks to the intricate embroidery detail and the washed out vintage feel. - [Multiparametric Flow Cytometry Overview Page 2024 - Invivoscribe](https://invivoscribe.com/mfc-overview/): Internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care. - [Invivoscribe - Navy Blue Distressed Vintage Hat - Invivoscribe](https://invivoscribe.com/shop/hats/invivoscribe-navy-blue-distressed-vintage-hat/): Expand your headwear collection with this fashionable dad hat. With a slightly distressed brim and crown fabric, it'll add just the right amount of edge to your look. For a quick and easy outfit pair it with slacks, your favorite jeans, and a sports tee. - [Invivoscribe Announces Updated Reimbursement for the LeukoStrat CDx FLT3 Mutation Assay to Select Newly Diagnosed FLT3-ITD Positive AML Patients Eligible for VANFLYTA in Japan - Invivoscribe](https://invivoscribe.com/invivoscribe-announces-updated-reimbursement-for-the-leukostrat-cdx-flt3-mutation-assay-to-select-newly-diagnosed-flt3-itd-positive-aml-patients-eligible-for-vanflyta-in-japan/): SAN DIEGO - May 25, 2023 - Invivoscribe Announces Updated Reimbursement for the LeukoStrat CDx FLT3 Mutation Assay? to Select Newly Diagnosed FLT3-ITD Positive AML Patients Eligible for VANFLYTA? in Japan SAN DIEGO - - [Application of cost effectiveness analysis to demonstrate the potential value of companion diagnostics in chronic myeloid leukemia - Invivoscribe](https://invivoscribe.com/application-of-cost-effectiveness-analysis-to-demonstrate-the-potential-value-of-companion-diagnostics-in-chronic-myeloid-leukemia/): Application of cost effectiveness analysis to demonstrate the potential value of companion diagnostics in chronic myeloid leukemia - [Invivoscribe Expands Ion PGM NGS Platform Menu: Releases Additional CE-IVD Clonality Kits with Bioinformatics Software and RUO Kits with MRD Software - Invivoscribe](https://invivoscribe.com/invivoscribe-expands-ion-pgm-ngs-platform-menu-releases-additional-ce-ivd-clonality-kits-with-bioinformatics-software-and-ruo-kits-with-mrd-software/): Invivoscribe Expands Ion PGM NGS Platform Menu: Releases Additional CE-IVD Clonality Kits with Bioinformatics Software and RUO Kits with MRD Software - [Invivoscribe Expands Long-Term Collaboration Agreement to Release FLT3 Mutation and Clonality Assay Kits - Invivoscribe](https://invivoscribe.com/invivoscribe-expands-long-term-collaboration-agreement-to-release-flt3-mutation-and-clonality-assay-kits/): Invivoscribe Expands Long-Term Collaboration Agreement to Release FLT3 Mutation and Clonality Assay Kit - [Study Suggests Critical Link Between Residual FLT3-ITD Mutations in Remission and Post-Transplant Outcomes in AML - Invivoscribe](https://invivoscribe.com/study-suggests-critical-link-between-residual-flt3-itd-mutations-in-remission-and-post-transplant-outcomes-in-aml/): Study Suggests Critical Link Between Residual FLT3-ITD Mutations in Remission and Post-Transplant Outcomes in AM - [Products - Best-In-Class Assays & Reagents - Invivoscribe](https://invivoscribe.com/products/): A full range of standardized CE-marked in vitro diagnostic cGMP products for hematology-oncology, as well as RUO assays, ASRs, DNA & RNA controls. - [Product & Service Catalogs - Invivoscribe](https://invivoscribe.com/product-service-catalogs/): Next-Generation Sequencing, ABI Fluorescence Detection, Gel Detection, Controls & Reagents, and Companion Diagnostics (CDx). - [Invivoscribe? Receives Approval in Japan for its LeukoStrat - CDx FLT3 Mutation Assay to Assess Acute Myeloid Leukemia (AML) Patients Eligible for Treatment with Xospata (gilteritinib fumarate) - Invivoscribe](https://invivoscribe.com/invivoscribe-receives-approval-in-japan-for-its-leukostrat-cdx-flt3-mutation-assay-to-assess-acute-myeloid-leukemia-aml-patients-eligible-for-treatment-with-xospata-gilteritinib/): Invivoscribe? Receives Approval in Japan for its LeukoStrat - CDx FLT3 Mutation Assay to Assess Acute Myeloid Leukemia (AML) Patients Eligible for Treatment with Xospata? (gilteritinib fumarate) - [Multiple Clonal Ig/TCR Products: Implications for Interpretation of Clonality Findings - Invivoscribe](https://invivoscribe.com/multiple-clonal-ig-tcr-products-implications-for-interpretation-of-clonality-findings/): Multiple Clonal Ig/TCR Products: Implications for Interpretation of Clonality Findings - [ASHEnd of Treatment Peripheral Blood TCR Evaluation for Minimal Residual Disease Evaluation in Peripheral T-cell Lymphomas - Invivoscribe](https://invivoscribe.com/end-of-treatment-peripheral-blood-tcr-evaluation-for-minimal-residual-disease-evaluation-in-peripheral-t-cell-lymphomas/): End of Treatment Peripheral Blood TCR Evaluation for Minimal Residual Disease Evaluation in Peripheral T-cell Lymphomas - [Clonality Of Multiple Distinct Lymphoproliferative Disorders Occurring Within Individual HIV+ Patients - Invivoscribe](https://invivoscribe.com/clonality-of-multiple-distinct-lymphoproliferative-disorders-occurring-within-individual-hiv-patients/): Clonality Of Multiple Distinct Lymphoproliferative Disorders Occurring Within Individual HIV+ Patient - [Clonally-Related CD5+ CLL/SLL and CD10+ high grade B-cell lymphoma suggests common neoplastic progenitor with branched disease evolution, with therapeutic implications - Invivoscribe](https://invivoscribe.com/clonally-related-cd5-cll-sll-and-cd10-high-grade-b-cell-lymphoma-suggests-common-neoplastic-progenitor-with-branched-disease-evolution-with-therapeutic-implications/): Clonally-Related CD5+ CLL/SLL and CD10+ high grade B-cell lymphoma suggests common neoplastic progenitor with branched disease evolution, with therapeutic implications - [Angioimmunoblastic T-cell lymphoma - Invivoscribe](https://invivoscribe.com/diseases/hematological-testing-guide/angioimmunoblastic-t-cell-lymphoma/): Angioimmunoblastic T-cell lymphom - [Hydroa Vacciniforme-like Lymphoma: A Chronic EBV+ Lymphoproliferative Disorder with Risk to Develop a Systemic Lymphoma - Invivoscribe](https://invivoscribe.com/hydroa-vacciniforme-like-lymphoma-a-chronic-ebv-lymphoproliferative-disorder-with-risk-to-develop-a-systemic-lymphoma/): Hydroa Vacciniforme-like Lymphoma: A Chronic EBV+ Lymphoproliferative Disorder with Risk to Develop a Systemic Lymphoma - [Assessment of MRD by NGS in Daily Clinical Management of Multiple Myeloma - Invivoscribe](https://invivoscribe.com/assessment-of-mrd-by-ngs-in-daily-clinical-management-of-multiple-myeloma/): Assessment of MRD by NGS in Daily Clinical Management of Multiple Myeloma - [Unlocking the Potential of NGS Clonality and MRD Testing: From Research to High-Throughput Environments - Part 02](https://invivoscribe.com/implementation-of-ngs-based-clonality-and-mrd-testing-in-a-high-throughput-environment/): Watch this video on Beyond systematic memory B-cell archiving: Mining B-cell receptor repertoires for antigen-specific clones and tumor cell precursors. - [Invivoscribe? Releases LeukoStrat? CDx FLT3 Mutation Assay as CE-marked IVD Assay Kit. - Invivoscribe](https://invivoscribe.com/invivoscribe-releases-leukostrat-cdx-flt3-mutation-assay-as-ce-marked-ivd-assay-kit/): Invivoscribe? Releases LeukoStrat? CDx FLT3 Mutation Assay as CE-marked IVD Assay Kit. - [ABI Fluorescence Detection (CE-IVD) - IdentiClone, FLT3, ITD, and TKD](https://invivoscribe.com/products/abi-fluorescence-detection/ce-ivd/): PCR-based assays for ABI fluorescence detection, including targeted FLT3 ITD, TKD mutation, B- and T-cell clonality, and translocation assays - [Invivoscribe - Laptop Sleeve (Version 02) - Invivoscribe](https://invivoscribe.com/shop/accessories/invivoscribe-laptop-sleeve-version-02/): Protect your laptop in style get this snug, lightweight laptop sleeve! To prevent any scratch marks, it contains an internal padded zipper and its interior is fully lined with faux fur. What's more, it's made from a material that's resistant to water, oil, and heat, making sure your laptop sleeve looks as sharp as you any - [Invivoscribe - Laptop Sleeve (Version 01) - Invivoscribe](https://invivoscribe.com/shop/accessories/invivoscribe-laptop-sleeve-version-01/): Protect your laptop in style get this snug, lightweight laptop sleeve! To prevent any scratch marks, it contains an internal padded zipper and its interior is fully lined with faux fur. What's more, it's made from a material that's resistant to water, oil, and heat, making sure your laptop sleeve looks as sharp as you any - [A Practical Approach to Diagnostic Ig/TCR Clonality Evaluation in Clinical Pathology - Invivoscribe](https://invivoscribe.com/a-practical-approach-to-diagnostic-ig-tcr-clonality-evaluation-in-clinical-pathology/): A Practical Approach to Diagnostic Ig/TCR Clonality Evaluation in Clinical Pathology - [Lymphoid and Myeloid Hematological Testing | LabPMM | Invivoscribe](https://invivoscribe.com/diseases/hematological-testing-guide/): Explore Invivoscribe's comprehensive hematological testing services and products for lymphoid and myeloid disorders. Find diagnostic solutions for your needs. - [Novartis drug PKC412 (midostaurin) receives Breakthrough Therapy designation from the FDA for newly-diagnosed FLT3-mutated acute myeloid leukemia (AML) - Invivoscribe](https://invivoscribe.com/invivoscribe-expanding-clinical-laboratory-network-space-and-testing-capabilities-in-san-diego-germany-japan-and-china-offering-comprehensive-standardized-testing-for-all-hematologic-malignancies-2-2/): Novartis drug PKC412 (midostaurin) receives Breakthrough Therapy designation from the FDA for newly-diagnosed FLT3-mutated acute myeloid leukemia (AML) - [Plan for a Successful International Drug Approval with Early Development of the Accompanying CDx - Invivoscribe](https://invivoscribe.com/plan-for-a-successful-international-drug-approval-with-early-development-of-the-accompanying-cdx/): Plan for a Successful International Drug Approval with Early Development of the Accompanying CDx - [Invivoscribe - Minimalist Backpack (Navy) - Invivoscribe](https://invivoscribe.com/shop/accessories/invivoscribe-minimalist-backpack-navy/): If you feel like you're carrying half of your belongings with you at all times, this backpack is for you! It has a spacious inside compartment (with a pocket for your laptop), and a hidden back pocket for safekeeping your most valuable items. - [VIRTUAL EHA: Incorporating NGS Methods for Routine Clonality Assessment and Disease Monitoring of Lymphoid Malignancies - Invivoscribe](https://invivoscribe.com/virtual-eha-incorporating-ngs-methods-for-routine-clonality-assessment-and-disease-monitoring-of-lymphoid-malignancies/): Incorporating NGS Methods for Routine Clonality Assessment and Disease Monitoring of Lymphoid Malignancies presented by Dr. Maria Arcila - Memorial Sloan - [Adult T-cell leukemia/lymphoma - Invivoscribe](https://invivoscribe.com/diseases/hematological-testing-guide/adult-t-cell-leukemia-lymphoma/): Adult T-cell leukemia/lymphoma - [LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients - Invivoscribe](https://invivoscribe.com/lymphotrack-is-equally-sensitive-as-pcr-genescan-and-sanger-sequencing-for-detection-of-clonal-rearrangements-in-all-patients/): LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patient - [Myeloproliferative neoplasms (MPN) - Invivoscribe](https://invivoscribe.com/diseases/hematological-testing-guide/myeloproliferative-neoplasms-mpn/): Myeloproliferative neoplasms (MPN) - [Roswell Park Comprehensive Cancer Center Licenses Invivoscribe?s LymphoTrack Software for Plug and Play Pipeline Use - Invivoscribe](https://invivoscribe.com/roswell-park-comprehensive-cancer-center-licenses-invivoscribes-lymphotrack-software-for-plug-and-play-pipeline-use/): Roswell Park Comprehensive Cancer Center Licenses Invivoscribe?s LymphoTrack Software for Plug and Play Pipeline Use - [Invivoscribe Submits the LeukoStrat CDx FLT3 Mutation Assay to Support Daiichi Sankyo Submission for Quizartinib in Japan - Invivoscribe](https://invivoscribe.com/invivoscribe-submits-the-leukostrat-cdx-flt3-mutation-assay-to-support-daiichi-sankyo-submission-for-quizartinib-in-japan/): Invivoscribe Submits the LeukoStrat CDx FLT3 Mutation Assay to Support Daiichi Sankyo Submission for Quizartinib in Japa - [Legal Notices - Invivoscribe](https://invivoscribe.com/legal-notices/): LEGAL NOTICES - [Invivoscribe Submits Pre-Market Approval Application in Japan and Panel Track Supplement in the US to Screen Acute Myeloid Leukemia (AML) Patients for FLT3 Mutations - Invivoscribe](https://invivoscribe.com/invivoscribe-submits-pre-market-approval-application-in-japan-and-panel-track-supplement-in-the-us-to-screen-acute-myeloid-leukemia-aml-patients-for-flt3-mutations/): Invivoscribe Submits Pre-Market Approval Application in Japan and Panel Track Supplement in the US to Screen Acute Myeloid Leukemia (AML) Patients for FLT3 Mutations - [T and B cell clonal expansion in Ras associated lymphoproliferative disease (RALD) as revealed by next generation sequencing - Invivoscribe](https://invivoscribe.com/t-and-b-cell-clonal-expansion-in-ras-associated-lymphoproliferative-disease-rald-as-revealed-by-next-generation-sequencing/): T and B cell clonal expansion in Ras associated lymphoproliferative disease (RALD) as revealed by next generation sequencing - [Invivoscribe - Cuffed Beanie (Version 01) - Invivoscribe](https://invivoscribe.com/shop/hats/invivoscribe-cuffed-beanie-version-01/): A snug, form-fitting beanie. It's not only a great head-warming piece but a staple accessory in anyone's wardrobe. - [In vitro co-expression of human amyloidogenic immunoglobulin light and heavy chain proteins: a relevant cell-based model of AL amyloidosis - Invivoscribe](https://invivoscribe.com/in-vitro-co-expression-of-human-amyloidogenic-immunoglobulin-light-and-heavy-chain-proteins-a-relevant-cell-based-model-of-al-amyloidosis/): In vitro co-expression of human amyloidogenic immunoglobulin light and heavy chain proteins: a relevant cell-based model of AL amyloidosis - [Invivoscribe Announces Key Submission in the EU, Expanded Presence and Activity in China - Invivoscribe](https://invivoscribe.com/invivoscribe-announces-key-submission-in-the-eu-expanded-presence-and-activity-in-china/): Invivoscribe Announces Key Submission in the EU, Expanded Presence and Activity in China - [Invivoscribe Announces FDA Approval of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with FLT3-ITD Positive AML for Treatment with VANFLYTA - Invivoscribe](https://invivoscribe.com/invivoscribe-announces-fda-approval-of-the-leukostrat-cdx-flt3-mutation-assay-to-select-patients-with-flt3-itd-positive-aml-for-treatment-with-vanflyta/): Invivoscribe Announces FDA Approval of the LeukoStrat? CDx FLT3 Mutation Assay to Select Patients with FLT3-ITD Positive AML for Treatment with VANFLYTA? - [The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies - Invivoscribe](https://invivoscribe.com/the-evolution-of-clonality-testing-in-the-diagnosis-and-monitoring-of-hematological-malignancies/): The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies - [FDA approves new combination treatment for acute myeloid leukemia - Invivoscribe](https://invivoscribe.com/fda-approves-new-combination-treatment-for-acute-myeloid-leukemia/): FDA approves new combination treatment for acute myeloid leukemia - [LymphoTrack MRD NGS | Invivoscribe](https://invivoscribe.com/lymphotrack-mrd-solutions/): Invivoscribe's measurable or minimal residual disease (MRD) monitoring uses highly sensitive LymphoTrack-enabled Ig/TR rearrangement detection. Learn more. - [NGS Analysis of Clonality and Minimal Residual Disease in a Patient with Concurrent Richter's Transformation and CLL/SLL - Invivoscribe](https://invivoscribe.com/ngs-analysis-of-clonality-and-minimal-residual-disease-in-a-patient-with-concurrent-richters-transformation-and-cll-sll/): NGS Analysis of Clonality and Minimal Residual Disease in a Patient with Concurrent Richter's Transformation and CLL/SLL - [Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients - Invivoscribe](https://invivoscribe.com/phenotypic-and-functional-characterization-of-t-cells-in-white-matter-lesions-of-multiple-sclerosis-patients/): Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients - [Invivoscribe - Women's Embroidered Polo Shirt (Version 01) - Invivoscribe](https://invivoscribe.com/shop/womens-clothing/invivoscribe-womens-embroidered-polo-shirt-version-01/): This semi-fitted women's polo shirt is just the right mix of relaxed and sporty for a brunch with friends, a long walk, or an evening on the sofa. And the stylish embroidery will definitely turn heads! - [Leveraging Standardized MRD Assays to Guide CLL Treatment - Invivoscribe](https://invivoscribe.com/leveraging-standardized-mrd-assays-to-guide-cll-treatment/): Leveraging Standardized MRD Assays to Guide CLL Treatment - [Invivoscribe Announces Long-Term Collaboration Agreement with Illumina and Plans Release of NGS-based IVD Assay Kits - Invivoscribe](https://invivoscribe.com/invivoscribe-announces-long-term-collaboration-agreement-with-illumina-and-plans-release-of-ngs-based-ivd-assay-kits/): Invivoscribe Announces Long-Term Collaboration Agreement with Illumina and Plans Release of NGS-based IVD Assay Kits - [AMP Comparing DNA Extraction Methods for the LymphoTrack? IVD TRG Assay - Invivoscribe](https://invivoscribe.com/comparing-dna-extraction-methods-for-the-lymphotrack-ivd-trg-assay/): Comparing DNA Extraction Methods for the LymphoTrack? IVD TRG Assay - [Invivoscribe - Minimalist Backpack (Royal) - Invivoscribe](https://invivoscribe.com/shop/accessories/invivoscribe-minimalist-backpack-royal/): If you feel like you're carrying half of your belongings with you at all times, this backpack is for you! It has a spacious inside compartment (with a pocket for your laptop), and a hidden back pocket for safekeeping your most valuable items. - [Invivoscribe - EHA 2019: Part 1 of 3 - Invivoscribe](https://invivoscribe.com/invivoscribe-eha-2019-part-1-of-3/): Invivoscribe - EHA 2019: Part 1 of 3 - [New Frontiers in Hematology: From CLL Tumor Precursor Cells to Tracking Disease Burden in Multiple Myeloma - Invivoscribe](https://invivoscribe.com/new-frontiers-in-hematology-from-cll-tumor-precursor-cells-to-tracking-disease-burden-in-multiple-myeloma/): New Frontiers in Hematology: From CLL Tumor Precursor Cells to Tracking Disease Burden in Multiple Myeloma - [Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma - Invivoscribe](https://invivoscribe.com/stability-and-uniqueness-of-clonal-immunoglobulin-cdr3-sequences-for-mrd-tracking-in-multiple-myeloma/): Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma - [Posters - Invivoscribe](https://invivoscribe.com/newsroom/posters/): LymphoTrack - Enterprise Software v3.0.1: A High-Throughput Software Solution for Immunogenomic Analysis - [A Systematic, Evidence-Based Workflow for Classifying KMT2A Fusions in AML - Invivoscribe](https://invivoscribe.com/a-systematic-evidence-based-workflow-for-classifying-kmt2a-fusions-in-aml/): Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia - [CDx Development | Invivoscribe](https://invivoscribe.com/partnerships/): Invivoscribe?s streamlined CDx development accelerates the international approval of new targeted therapies. Contact us today for partnership inquiries. - [Evaluation of the polymerase chain reaction based T-cell receptor's clonality test in the diagnosis of early mycosis fungoides - Invivoscribe](https://invivoscribe.com/evaluation-of-the-polymerase-chain-reaction-based-t-cell-receptor-?-clonality-test-in-the-diagnosis-of-early-mycosis-fungoides/): Evaluation of the polymerase chain reaction's based T-cell receptor? clonality test in the diagnosis of early mycosis fungoides - [Evaluation of next-generation sequencing versus next-generation flow cytometry for minimal residual disease detection in Chinese patients with multiple myeloma - Invivoscribe](https://invivoscribe.com/next-generation-flow-cytometry-for-mrd-detection-in-chinese-patients-with-multiple-myeloma/): Evaluation of next-generation sequencing versus next-generation flow cytometry for minimal residual disease detection in Chinese patients with multiple myeloma - [A Small Case Series of Intravascular Large B-Cell Lymphoma with Unexpected Findings: Subset of Cases with Concomitant Extravascular Central Nervous System (CNS) Involvement Mimicking Primary CNS Lymphoma - Invivoscribe](https://invivoscribe.com/a-small-case-series-of-intravascular-large-b-cell-lymphoma-with-unexpected-findings-subset-of-cases-with-concomitant-extravascular-central-nervous-system-cns-involvement-mimicking-primary-cns-lymph/): A Small Case Series of Intravascular Large B-Cell Lymphoma with Unexpected Findings: Subset of Cases with Concomitant Extravascular Central Nervous System (CNS) Involvement Mimicking Primary CNS Lymphoma - [Invivoscribe Expands Business into Solid Tumors with Assays and Services to Identify and Monitor CAR-T and TCR Immuno-Therapies - Invivoscribe](https://invivoscribe.com/invivoscribe-expands-business-into-solid-tumors-with-assays-and-services-to-identify-and-monitor-car-t-and-tcr-immuno-therapies/): Invivoscribe Expands Business into Solid Tumors with Assays and Services to Identify and Monitor CAR-T and TCR Immuno-Therapies - [Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial - Invivoscribe](https://invivoscribe.com/invivoscribe-expands-flow-cytometry-services-to-accelerate-car-t-immunotherapy-development-and-regulatory-readiness-with-the-initiation-of-cero-therapeutics-phase-1-clinical-trial/): Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial - [AMP Validation of an NGS based assay for monitoring FLT3 ITD and TKD variants in AML subjects - Invivoscribe](https://invivoscribe.com/validation-of-an-ngs-based-assay-for-monitoring-flt3-itd-and-tkd-variants-in-aml-subjects/): Validation of an NGS based assay for monitoring FLT3 ITD and TKD variants in AML subjects - [The European Commission Approves Astellas? XOSPATA? for Patients with Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation Detected by Validated Tests, including the Invivoscribe LeukoStrat CDx FLT3 Mutation Assay - Invivoscribe](https://invivoscribe.com/the-european-commission-approves-astellas-xospata-for-patients-with-relapsed-or-refractory-acute-myeloid-leukemia-with-a-flt3-mutation-detected-by-validated-tests-including-the-invivos/): The European Commission Approves Astellas? XOSPATA? for Patients with Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation Detected by Validated Tests, including the Invivoscribe LeukoStrat CDx FLT3 Mutation Assay ##Entries Q: Can I run the LeukoStrat® CDx FLT3 Mutation assay in my own laboratory or must I have the test run at LabPMM (Invivoscribe's Clinical Lab Service)? A: The assay can be purchased as a diagnostic kit for use in your own laboratory. Alternatively, a sample can be sent to LabPMM for testing and the results will be sent to your facility within 2-3 business days. Q: What does the LeukoStrat® CDx FLT3 Mutation Assay kit include? A: Our LeukoStrat® CDx FLT3 Mutation Assay kit includes TKD and ITD master mixes, TKD positive and negative controls, ITD positive and negative controls, an extraction control, Taq DNA polymerase*, EcoRV* and buffer*, and LeukoStrat® CDx FLT3 Mutation Assay software. This comprehensive package is simple to use, reduces user error, and has a rapid TAT. (*not included in catalog no. K4120291) Q: Our lab does not have an ABI 3500xL Dx Genetic Analyzer capillary electrophoresis instrument, will the assay work on an ABI 3500xL Genetic Analyzer? A: The LeukoStrat® CDx FLT3 ITD Mutation assay was validated using the ABI 3500xL Dx Genetic Analyzer, if an alternate instrument is used it would need to be validated. ~~~ ## llms-full Not found.